Skip to main content

Market Overview

UPDATE: Canaccord Genuity Reiterates Buy Rating, Raises PT on SunOpta


In a report published Monday, Canaccord Genuity reiterated its Buy rating on SunOpta (NASDAQ: STKL), and slightly raised its price target from $7.50 to $8.50.

Canaccord Genuity noted, “We continue to believe that SunOpta's focus on natural and organic products will deliver favorable growth with earnings further benefitting from a refocusing on its core food platforms. California's Prop 37 ballot initiative requiring the labeling of genetically modified foods looks likely to pass as a recent poll shows Californians support the measure roughly 3 to 1. SunOpta is best positioned to see an almost immediate business acceleration as we expect the food industry to respond with attempts to reformulate some of its offerings as non-GMO in order to avoid mandatory labeling.”

SunOpta closed on Friday at $6.69.

Latest Ratings for STKL

Apr 2021Canaccord GenuityInitiates Coverage OnBuy
Dec 2020Craig-HallumInitiates Coverage OnBuy
Jul 2020DA DavidsonInitiates Coverage OnBuy

View More Analyst Ratings for STKL
View the Latest Analyst Ratings


Related Articles (STKL)

View Comments and Join the Discussion!

Posted-In: Canaccord GenuityAnalyst Color Price Target Analyst Ratings

Latest Ratings

ICADGuggenheimInitiates Coverage On24.0
SMBKRaymond JamesUpgrades27.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at